Copyright Reports & Markets. All rights reserved.

Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Tamoxifen
      • 1.4.3 Aromatase Inhibitors
      • 1.4.4 Antiandrogens
      • 1.4.5 Androgen Synthesis Inhibitors
      • 1.4.6 Other
    • 1.5 Market by Application
      • 1.5.1 Global Cancer Hormone Therapy Drugs Market Share by Application (2014-2025)
      • 1.5.2 Breast Cancer
      • 1.5.3 Prostate Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cancer Hormone Therapy Drugs Market Size
    • 2.2 Cancer Hormone Therapy Drugs Growth Trends by Regions
      • 2.2.1 Cancer Hormone Therapy Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Cancer Hormone Therapy Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cancer Hormone Therapy Drugs Market Size by Manufacturers
      • 3.1.1 Global Cancer Hormone Therapy Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
    • 3.3 Key Players Cancer Hormone Therapy Drugs Product/Solution/Service
    • 3.4 Date of Enter into Cancer Hormone Therapy Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cancer Hormone Therapy Drugs Market Size by Type (2014-2019)
    • 4.2 Global Cancer Hormone Therapy Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 5.2 Cancer Hormone Therapy Drugs Key Players in United States
    • 5.3 United States Cancer Hormone Therapy Drugs Market Size by Type
    • 5.4 United States Cancer Hormone Therapy Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 6.2 Cancer Hormone Therapy Drugs Key Players in Europe
    • 6.3 Europe Cancer Hormone Therapy Drugs Market Size by Type
    • 6.4 Europe Cancer Hormone Therapy Drugs Market Size by Application

    7 China

    • 7.1 China Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 7.2 Cancer Hormone Therapy Drugs Key Players in China
    • 7.3 China Cancer Hormone Therapy Drugs Market Size by Type
    • 7.4 China Cancer Hormone Therapy Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 8.2 Cancer Hormone Therapy Drugs Key Players in Japan
    • 8.3 Japan Cancer Hormone Therapy Drugs Market Size by Type
    • 8.4 Japan Cancer Hormone Therapy Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 9.2 Cancer Hormone Therapy Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Type
    • 9.4 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Application

    10 India

    • 10.1 India Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 10.2 Cancer Hormone Therapy Drugs Key Players in India
    • 10.3 India Cancer Hormone Therapy Drugs Market Size by Type
    • 10.4 India Cancer Hormone Therapy Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cancer Hormone Therapy Drugs Market Size (2014-2019)
    • 11.2 Cancer Hormone Therapy Drugs Key Players in Central & South America
    • 11.3 Central & South America Cancer Hormone Therapy Drugs Market Size by Type
    • 11.4 Central & South America Cancer Hormone Therapy Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cancer Hormone Therapy Drugs Introduction
      • 12.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Amgen
      • 12.2.1 Amgen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cancer Hormone Therapy Drugs Introduction
      • 12.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.2.5 Amgen Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cancer Hormone Therapy Drugs Introduction
      • 12.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Teva
      • 12.4.1 Teva Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cancer Hormone Therapy Drugs Introduction
      • 12.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.4.5 Teva Recent Development
    • 12.5 Takeda
      • 12.5.1 Takeda Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cancer Hormone Therapy Drugs Introduction
      • 12.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.5.5 Takeda Recent Development
    • 12.6 Samyang Biopharmaceuticals
      • 12.6.1 Samyang Biopharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cancer Hormone Therapy Drugs Introduction
      • 12.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.6.5 Samyang Biopharmaceuticals Recent Development
    • 12.7 Tolmar
      • 12.7.1 Tolmar Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cancer Hormone Therapy Drugs Introduction
      • 12.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.7.5 Tolmar Recent Development
    • 12.8 AstraZeneca
      • 12.8.1 AstraZeneca Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cancer Hormone Therapy Drugs Introduction
      • 12.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.8.5 AstraZeneca Recent Development
    • 12.9 Novartis
      • 12.9.1 Novartis Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cancer Hormone Therapy Drugs Introduction
      • 12.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.9.5 Novartis Recent Development
    • 12.10 Aspen
      • 12.10.1 Aspen Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cancer Hormone Therapy Drugs Introduction
      • 12.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2014-2019)
      • 12.10.5 Aspen Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
      In 2018, the global Cancer Hormone Therapy Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cancer Hormone Therapy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Hormone Therapy Drugs development in United States, Europe and China.

      The key players covered in this study
      Roche
      Amgen
      Pfizer
      Teva
      Takeda
      Samyang Biopharmaceuticals
      Tolmar
      AstraZeneca
      Novartis
      Aspen

      Market segment by Type, the product can be split into
      Tamoxifen
      Aromatase Inhibitors
      Antiandrogens
      Androgen Synthesis Inhibitors
      Other

      Market segment by Application, split into
      Breast Cancer
      Prostate Cancer

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cancer Hormone Therapy Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Cancer Hormone Therapy Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cancer Hormone Therapy Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now